Cargando…

SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer

Mostrar otras versiones (1)

Correction to: British Journal of Cancer (2002) 87, 630–634. doi:10.1038/sj.bjc.6600511

Detalles Bibliográficos
Autores principales:	Boulay, J-L, Mild, G, Lowy, A, Reuter, J, Lagrange, M, Terracciano, L, Laffer, U, Herrmann, R, Rochlitz, C
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2003
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394240/ http://dx.doi.org/10.1038/sj.bjc.6601020

Ejemplares similares

SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer
por: Boulay, J-L, et al.
Publicado: (2002)

Infrequent mutation of the tumour-suppressor gene Smad4 in early-stage colorectal cancer
por: Mamot, C, et al.
Publicado: (2003)

Topoisomerase I and IIα protein expression in primary colorectal cancer and recurrences following 5-fluorouracil-based adjuvant chemotherapy
por: Tsavaris, Nicolas, et al.
Publicado: (2009)

Erratum to: Phase II trial of biweekly docetaxel, cisplatin, and 5-fluorouracil chemotherapy for advanced esophageal squamous cell carcinoma
por: Tanaka, Yoshihiro, et al.
Publicado: (2016)

Co-delivery of 5-fluorouracil and miRNA-34a mimics by host-guest self-assembly nanocarriers for efficacious targeted therapy in colorectal cancer patient-derived tumor xenografts: Erratum
por: Xu, Jianbin, et al.
Publicado: (2022)

Loss of Smad4 in colorectal cancer induces resistance to 5-fluorouracil through activating Akt pathway
por: Zhang, B, et al.
Publicado: (2014)

Management of neovascular glaucoma with intravitreal ranibizumab, panretinal photocoagulation, and subsequent 5-fluorouracil augmented trabeculectomy: A case report: Erratum
Publicado: (2017)

Erratum to: Calnexin, an ER stress-induced protein, is a prognostic marker and potential therapeutic target in colorectal cancer
por: Ryan, Deborah, et al.
Publicado: (2016)

Identification of Genes Related to 5-Fluorouracil Based Chemotherapy for Colorectal Cancer
por: Huang, Xingxing, et al.
Publicado: (2022)

Impact of 5-fluorouracil metabolizing enzymes on chemotherapy in patients with resectable colorectal cancer
por: OCHIAI, TAKUMI, et al.
Publicado: (2014)

Erratum to: Efficacy and Safety of 5-Fluorouracil 0.5%/Salicylic Acid 10% in the Field-Directed Treatment of Actinic Keratosis: A Phase III, Randomized, Double-Blind, Vehicle-Controlled Trial
por: Stockfleth, Eggert, et al.
Publicado: (2017)

Identification of Epithelial-Mesenchymal Transition-related Target Genes Induced by the Mutation of Smad3 Linker Phosphorylation
por: Park, Sujin, et al.
Publicado: (2018)

Erratum: Loss of SMAD3 Promotes Vascular Remodeling in Pulmonary Arterial Hypertension via MRTF Disinhibition
Publicado: (2019)

Erratum to: hCLP46 increases Smad3 protein stability via inhibiting its ubiquitin-proteasomal degradation
por: Xing, Yingying, et al.
Publicado: (2015)

Delivery of Rapamycin by Liposomes Synergistically Enhances the Chemotherapy Effect of 5-Fluorouracil on Colorectal Cancer
por: Chen, Yi-Qing, et al.
Publicado: (2021)

Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy
por: Paré, L, et al.
Publicado: (2008)

Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy
por: Paré, L, et al.
Publicado: (2009)

The effect of 5-fluorouracil and alpha interferon and 5-fluorouracil and leucovorin on cellular anti-tumour immune responses in patients with advanced colorectal cancer.
por: Nichols, P. H., et al.
Publicado: (1994)

Multi-omics landscapes of colorectal cancer subtypes discriminated by an individualized prognostic signature for 5-fluorouracil-based chemotherapy
por: Tong, M, et al.
Publicado: (2016)

Erratum to: Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study
por: Escobar, Yolanda, et al.
Publicado: (2015)

Erratum to: Transforming Growth Factor b1/Smad4 Signaling Affects Osteoclast Differentiation via Regulation of miR-155 Expression
por: Zhao, Hongying, et al.
Publicado: (2017)

Erratum to “MiRNA-10b Reciprocally Stimulates Osteogenesis and Inhibits Adipogenesis Partly through the TGF-β/SMAD2 Signaling Pathway”
por: Li, Hongling, et al.
Publicado: (2021)

Erratum to: “Microvascular manifestations revealing vaccine-induced thrombotic thrombocytopenia after COVID-19 vaccination” [J. Med. Vasc. 47 (2022) 36–38]
por: Noyé, M., et al.
Publicado: (2022)

Markers of inflammation in periodontal diseases
por: Nędzi-Góra, M, et al.
Publicado: (2016)

ERRATUM: Correction for affiliation of the 8(th) author-corresponding author. Multicenter nonrandomized trial of ramosetron versus palonosetron in controlling chemotherapy-induced nausea and vomiting for colorectal cancer
por: Kim, Jin Soo, et al.
Publicado: (2014)

Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours
por: Turner, N C, et al.
Publicado: (2010)

Consumption of Lactose, Other FODMAPs and Diarrhoea during Adjuvant 5-Fluorouracil Chemotherapy for Colorectal Cancer
por: Holma, Reetta, et al.
Publicado: (2020)

Thymidylate synthase expression in primary colorectal cancer as a predictive marker for the response to 5-fluorouracil- and oxaliplatin-based preoperative chemotherapy for liver metastases
por: Takeyama, Hiroshi, et al.
Publicado: (2018)

5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highly effective, low-cost chemotherapy for advanced colorectal cancer
por: Sobrero, A, et al.
Publicado: (2001)

A phase-III study of recombinant interleukin 2 and 5-fluorouracil chemotherapy in patients with metastatic colorectal cancer.
por: Hamblin, T. J., et al.
Publicado: (1993)

Erratum to: Gemcitabine plus capecitabine (Gem–Cape) biweekly in chemorefractory metastatic colorectal cancer
por: Jiménez-Fonseca, P., et al.
Publicado: (2014)

Streptozocin/5-fluorouracil chemotherapy of pancreatic neuroendocrine tumours in the era of targeted therapy
por: Lahner, Harald, et al.
Publicado: (2021)

A Meta-Analysis of SMAD4 Immunohistochemistry as a Prognostic Marker in Colorectal Cancer()()
por: Voorneveld, Philip W., et al.
Publicado: (2015)

ERRATUM: Comparison of Surgery Plus Chemotherapy and Palliative Chemotherapy Alone for Advanced Gastric Cancer with Krukenberg Tumor
por: Cho, Jang Ho, et al.
Publicado: (2018)

Erratum to: The effect of chemotherapy on expression of folate receptor-alpha in ovarian cancer
por: Crane, Lucia M. A., et al.
Publicado: (2012)

Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas
por: Bain, G H, et al.
Publicado: (2016)

Erratum to: ‘Genomic structure and marker-derived gene networks for growth and meat quality traits of Brazilian Nelore beef cattle’
por: Mudadu, Maurício A., et al.
Publicado: (2016)

Erratum: Infrequently expressed miRNAs in colorectal cancer tissue and tumor molecular phenotype
por: Slattery, Martha L, et al.
Publicado: (2018)

Erratum to: Eighteen year weight trajectories and metabolic markers of diabetes in modernising China
por: Gordon-Larsen, Penny, et al.
Publicado: (2014)

GOLPH3 predicts survival of colorectal cancer patients treated with 5-fluorouracil-based adjuvant chemotherapy
por: Wang, Zaozao, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_4v5g49khf4u5ohina2povsn921